Renalytix Piotroski F Score

RTNXF -  USA Stock  

USD 12.30  3.28  36.36%

This module uses fundamental data of Renalytix Plc to approximate its Piotroski F score. Renalytix Plc F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Renalytix Plc. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Renalytix Plc financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Additionally, take a look at Renalytix Plc Altman Z Score, Renalytix Plc Correlation, Renalytix Plc Valuation, as well as analyze Renalytix Plc Alpha and Beta and Renalytix Plc Hype Analysis.

Renalytix Piotroski F Score 

 
Refresh
At this time, it appears that Renalytix Plc's Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
0.0
Piotroski F Score - Unavailable
1
Current Return On Assets
N/A
2
Change in Return on Assets
N/A
3
Cash Flow Return on Assets
N/A
4
Current Quality of Earnings (accrual)
N/A
5
Asset Turnover Growth
N/A
6
Current Ratio Change
N/A
7
Long Term Debt Over Assets Change
N/A
8
Change In Outstending Shares
N/A
9
Change in Gross Margin
N/A

Renalytix Plc Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Renalytix Plc is to make sure Renalytix is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Renalytix Plc's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Renalytix Plc's financial numbers are properly reported.

About Renalytix Plc Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

About Renalytix Plc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Renalytix Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Renalytix Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Renalytix Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Renalytix AI plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record, and systems to generate a unique patient risk score. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. Renalytix AI plc was founded in 2018 and is based in Cardiff, the United Kingdom.

Renalytix Plc Investors Sentiment

The influence of Renalytix Plc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Renalytix. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - RTNXF

Renalytix Plc Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in Renalytix Plc. What is your perspective on investing in Renalytix Plc? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Currently Active Assets on Macroaxis

Additionally, take a look at Renalytix Plc Altman Z Score, Renalytix Plc Correlation, Renalytix Plc Valuation, as well as analyze Renalytix Plc Alpha and Beta and Renalytix Plc Hype Analysis. Note that the Renalytix Plc information on this page should be used as a complementary analysis to other Renalytix Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Renalytix OTC Stock analysis

When running Renalytix Plc price analysis, check to measure Renalytix Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix Plc is operating at the current time. Most of Renalytix Plc's value examination focuses on studying past and present price action to predict the probability of Renalytix Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Renalytix Plc's price. Additionally, you may evaluate how the addition of Renalytix Plc to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
The market value of Renalytix Plc is measured differently than its book value, which is the value of Renalytix that is recorded on the company's balance sheet. Investors also form their own opinion of Renalytix Plc's value that differs from its market value or its book value, called intrinsic value, which is Renalytix Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renalytix Plc's market value can be influenced by many factors that don't directly affect Renalytix Plc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renalytix Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine Renalytix Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.